Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000058C4
CNY
23.85
-1.11 (-4.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
232.47
254.37
223.30
252.63
282.03
286.32
324.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
232.47
254.37
223.30
252.63
282.03
286.32
324.91
Raw Material Cost
76.70
71.43
52.56
54.29
53.64
51.40
54.65
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
34.70
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.47
0.11
0.08
0.03
0.04
0.04
0.04
Selling and Distribution Expenses
129.85
136.68
133.91
146.68
163.46
172.92
186.90
Other Expenses
-2.66
0.79
0.86
1.17
1.33
0.43
1.65
Total Expenditure (Excl Depreciation)
215.07
216.15
195.17
212.72
230.42
228.69
258.12
Operating Profit (PBDIT) excl Other Income
17.4
38.199999999999996
28.1
39.900000000000006
51.6
57.599999999999994
66.8
Other Income
8.99
11.40
31.58
13.00
10.90
10.43
7.28
Operating Profit (PBDIT)
56.05
68.42
73.84
67.70
77.64
79.42
85.12
Interest
0.47
0.11
0.08
0.03
0.04
0.04
0.04
Exceptional Items
0.94
0.74
3.15
1.17
0.00
0.00
0.00
Gross Profit (PBDT)
155.78
182.95
170.74
198.33
228.38
234.91
270.26
Depreciation
35.52
22.53
18.60
18.41
18.40
20.46
20.67
Profit Before Tax
21.00
46.51
58.31
50.43
59.21
58.93
64.41
Tax
1.10
6.25
7.81
9.71
7.19
9.18
9.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
21.90
40.27
50.50
40.72
52.02
49.74
54.61
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
21.90
40.27
50.50
40.72
52.02
49.74
54.61
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.90
40.27
50.50
40.72
52.02
49.74
54.61
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
904.27
905.75
982.86
945.29
524.14
472.12
446.62
Earnings per share (EPS)
0.29
0.52
0.62
0.5
0.64
0.62
0.68
Diluted Earnings per share
0.29
0.52
0.62
0.5
0.64
0.62
0.68
Operating Profit Margin (Excl OI)
4.96%
13.56%
10.6%
14.37%
17.14%
16.95%
17.6%
Gross Profit Margin
24.31%
27.14%
34.44%
27.25%
27.52%
27.73%
26.19%
PAT Margin
9.42%
15.83%
22.62%
16.12%
18.44%
17.37%
16.81%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -8.61% vs 13.93% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -50.62% vs -20.20% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -17.37% vs 34.75% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 400.00% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
232.47
0
232.47
Other Operating Income
0.00
0.00
0.00
Total Operating income
232.47
0
232.47
Raw Material Cost
76.70
0
76.70
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
34.70
0
34.70
Power Cost
0
0
0.00
Manufacturing Expenses
0.47
0
0.47
Selling and Distribution Expenses
129.85
0
129.85
Other Expenses
-2.66
0.00
-2.66
Total Expenditure (Excl Depreciation)
215.07
0
215.07
Operating Profit (PBDIT) excl Other Income
17.40
0.00
17.40
Other Income
8.99
0
8.99
Operating Profit (PBDIT)
56.05
0
56.05
Interest
0.47
0
0.47
Exceptional Items
0.94
0
0.94
Gross Profit (PBDT)
155.78
0
155.78
Depreciation
35.52
0
35.52
Profit Before Tax
21.00
0
21.00
Tax
1.10
0
1.10
Provisions and contingencies
0
0
0.00
Profit After Tax
21.90
0
21.90
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
21.90
0
21.90
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.00
0
-2.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.90
0
19.90
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
904.27
0
904.27
Earnings per share (EPS)
0.29
0
0.29
Diluted Earnings per share
0.29
0
0.29
Operating Profit Margin (Excl OI)
4.96%
0%
0.00
4.96%
Gross Profit Margin
24.31%
0%
0.00
24.31%
PAT Margin
9.42%
0%
0.00
9.42%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 23.25 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -8.61% vs 13.93% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 1.99 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -50.62% vs -20.20% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.71 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -17.37% vs 34.75% in Dec 2024

Annual - Interest
Interest 0.05 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 400.00% vs 0.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.96%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024